Contingency Management for Smoking Cessation in Adolescent Smokers - Phase IV, Enhancing a High School Based Smoking Cessation Program
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 154
- 试验地点
- 1
- 主要终点
- Abstinence Rates at the End of Treatment
研究概览
简要总结
The purpose of this study is to examine the the efficacy of adjunctive nicotine replacement therapy when used in combination with the contingency management (CM) + cognitive behavioral therapy intervention. Subjects will be randomly assigned to receive either a nicotine transdermal patch or a placebo patch as well as being randomly assigned to receive either CM or no CM; all subjects will receive cognitive behavioral therapy. We hypothesize that that subjects receiving both active nicotine patch and CM will have higher rates of abstinence from tobacco than subjects in the other groups.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Care Provider)
入排标准
- 年龄范围
- 14 Years 至 19 Years（Child, Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •High School aged
- •Desire to quit smoking
- •Smoking >5 cigarettes per day
- •Able to read and write in English
排除标准
- •Current dependence on other substances
- •Medical conditions that would contraindicate the use of a nicotine patch
研究组 & 干预措施
Active Nicotine Patch and Contingency Management
Subjects in this group will receive Contingency Management and active nicotine patch
干预措施: Cognitive Behavioural Therapy (Behavioral)
Active Nicotine Patch and Contingency Management
Subjects in this group will receive Contingency Management and active nicotine patch
干预措施: Contingency Management (Behavioral)
Active Nicotine Patch and Contingency Management
Subjects in this group will receive Contingency Management and active nicotine patch
干预措施: Nicotine Transdermal Patch (Drug)
Nicotine Patch with no Contingency Management
Subjects in this group will receive active nicotine patch without contingency management for abstinence
干预措施: Cognitive Behavioural Therapy (Behavioral)
Nicotine Patch with no Contingency Management
Subjects in this group will receive active nicotine patch without contingency management for abstinence
干预措施: Nicotine Transdermal Patch (Drug)
Placebo patch and Contingency Management
Subjects in this group will receive a placebo transdermal patch and contingency management
干预措施: Cognitive Behavioural Therapy (Behavioral)
Placebo patch and Contingency Management
Subjects in this group will receive a placebo transdermal patch and contingency management
干预措施: Contingency Management (Behavioral)
Placebo Patch and no Contingency Management
Subjects in this group will receive a placebo patch and will not receive contingency management
干预措施: Cognitive Behavioural Therapy (Behavioral)
结局指标
主要结局
Abstinence Rates at the End of Treatment
时间窗: 6 weeks
Our primary outcome will be point prevalence abstinence at the end of the treatment period defined as any self-report of cigarette use during the seven days prior to the last appointment confirmed by urine analysis.
次要结局
- Continuous Abstinence During Treatment(6 weeks)